GlobalCapital - New York, NY Bureau covers News

Background and Format: The Cover is an online daily news service dedicated to the covered bond market, published by GlobalCapital. It delivers live breaking news on new covered bond issues as they are launched, as well as essential information on the secondary markets, priced deals data and covered bond regulation and the people that matter in the covered bond markets. The Cover also generates league tables on the market. It is a subscriber service. 

Background and Format: Published by Euromoney Institutional Investor PLC, GlobalCapital Derivatives forms one part of the GlobalCapital online resource. Previously a weekly magazine titled Derivatives Intelligence, GlobalCapital Derivatives now produces a daily global e-newsletter covering the derivatives market. This title provides news, information, proprietary databases and informed perspective pieces on derivatives worldwide. It also addresses regulatory challenges, and speaks to banks and issuers making deals in Europe, the Americas, the Far East and across emerging markets. Audience and Readership: Targets derivatives investors, including institutional investors and hedge funds, both long-term and new. Deadline: Ongoing Frequency: The newsletter is emailed daily to subscribers. Circulation: They do not disclose a figure for number of subscribers. Ad Rates: For advertising information and contact details, please click here. Other Information: There is no generic editorial email address; enquiries should be sent directly to the most relevant individual. Can be found on GooglePlus here The RSS feed can be viewed here Alerts: Gorkana Alert: Monday 3 March 2014 EuroWeek is relaunching today as GlobalCapital. The new title also incorporates AsiaMoney, Derivatives Week and Total Securitization and is the launch platform for GlobalRMB, a news and data service on the offshore renminbi market. GlobalCapital will also continue to take the form of a weekly print title covering global capital markets. The website for GlobalCapital can now be found at www.globalcapital.com. Managing Editor Toby Fildes can be reached on +44 (0)20 7779 7327 and toby.fildes@globalcapital.com

Background and Format: GlobalCustody.net is a provider of information on custody and fund administration resources such as service providers and service offerings, rankings and ratings, and news and events. Audience and Readership: The service is aimed at fund managers, institutional investors, broker-dealers and custodians. Deadline: Ongoing Frequency: Online Monthly Unique Users: The MUU figure is not disclosed. Distribution: Online Ad rates: For ad rates contact via the website contact facility box. The media pack can be found here. <w:LsdException Locked="false" Priority="64" SemiHidden="false" UnhideWhenUsed="false" Name="Med

BioPharm Insight (BPI) is a team of investigative journalists, and owned by the Financial Times Group. The editorial team operates out of New York, London and Shanghai and covers a pipeline of events by aggregating and reviewing data about thousands of upcoming pivotal drug development events, plus equity research, Wall Street data, industry news releases, and historical coverage. The news operation is only one part of an online business intelligence system that also includes market analytics, and a database of industry contacts. The team covers everything in healthcare, from drug development and research, partnerships/licensing, M&A, regulatory, reimbursement, medical devices, healthcare services, CROs, CMOs, among others. The majority of their journalists have graduate degrees in the sciences, or years of scientific reporting. They are versed in understanding clinical trials data, as well as deciphering statistics. This enables BPI to uncover news and build relationship with doctors, scientists, company executives and other opinion leaders. BioPharm Insight is published by Infinata, part of the Financial Times Group of companies and a division of Pearson plc. BioPharm Insight does not provide user/circulation figures.   New York DMA

BioPharm Insight (BPI) is a team of investigative journalists, and owned by the Financial Times Group. The editorial team operates out of New York, London and Shanghai and covers a pipeline of events by aggregating and reviewing data about thousands of upcoming pivotal drug development events, plus equity research, Wall Street data, industry news releases, and historical coverage. The news operation is only one part of an online business intelligence system that also includes market analytics, and a database of industry contacts. The team covers everything in healthcare, from drug development and research, partnerships/licensing, M&A, regulatory, reimbursement, medical devices, healthcare services, CROs, CMOs, among others. The majority of their journalists have graduate degrees in the sciences, or years of scientific reporting. They are versed in understanding clinical trials data, as well as deciphering statistics. This enables BPI to uncover news and build relationship with doctors, scientists, company executives and other opinion leaders. BioPharm Insight is published by Infinata, part of the Financial Times Group of companies and a division of Pearson plc. BioPharm Insight does not provide user/circulation figures.

Background and Format: GlobalDatingInsights.com provides users with breaking news stories, features and aims for high quality editorial throughout the global online dating industry. Audience and Readership: A global audience made-up of on-line dating executives, managers and industry stakeholders. Monthly Unique Users: Source: Publisher Ad Rates: Further information on advertising can be viewed here.

Impact Factor: 2.540 Monthly Unique Users: The Publisher does not disclose the figure Frequency: Website Affiliations: London School of Economics (LSE Health) Aims of the Journal: Globalization and Health is an open access, peer-reviewed, online journal that provides an international forum for high quality original research, knowledge sharing and debate on the topic of globalization and its effects on health, both positive and negative. Readership: The output of the journal is useful to a wide audience interested in global health, including academics, policy-makers, health care practitioners, and public health professionals. Content: The journal focuses on advancing the conceptual and theoretical tenets, empirical evidence base, and policy applications relevant to globalization and health. Related issues include the SARS virus and its control, the politics of the tobacco industry, the 'Westernization' of lifestyle behaviours and associated health implications, and access to essential medicines. The relationship between globalization and health assumes a broad lens and multidisciplinary approach, attending to the multitude of factors that directly and indirectly impact upon health. Editorial Contacts: For editorial enquiries contact globalizationandhealth@biomedcentral.com. Manuscript Submission: Instructions for authors can be viewed at www.globalizationandhealth.com/authors/instructions

Provides news and information on the Defense Language Institute Foreign Language Center (DLIFLC), which educates students who come from every branch of the U.S. Armed Forces.